Completed

Cognition, Steroids, and Imaging in Cushings Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Adenoma+16

+ Adrenal Gland Diseases

+ Adrenocortical Hyperfunction

Over 9 Years
See all eligibility criteria
How is the trial designed

Observational
See protocol details

Summary

Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

This study investigates the effects of the glucocorticoid hormone cortisol on brain structure and function. Patients with Cushing's disease are studied before and after treatment. Brain imaging and neuropsychologic tests are used to study changes in the hippocampus and thinking and learning functions as well as mood during the period of elevated cortisol. At several intervals after treatment, these are reexamined to study the degree of reversibility of the abnormalities. The contribution of cortisol as well as testosterone and estrogen to dysfunction and recovery is studied. Since elevated cortisol and dysregulation of its secretory system occurs in a significant proportion of the aged and in Alzheimers Disease and Major Depressive Disorder, these studies will help advance knowledge of the role of cortisol in these conditions.

Official TitleCognition, Steroids, and Imaging in Cushings Disease 
NCT00081341
Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 9 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AdenomaAdrenal Gland DiseasesAdrenocortical HyperfunctionBrain DiseasesCentral Nervous System DiseasesCushing SyndromeEndocrine System DiseasesEndocrine Gland NeoplasmsHyperpituitarismHypothalamic DiseasesNeoplasmsNeoplasms by Histologic TypeNeoplasms by SiteNeoplasms, Glandular and EpithelialNervous System DiseasesPituitary DiseasesPituitary NeoplasmsPituitary ACTH HypersecretionACTH-Secreting Pituitary Adenoma

Criteria

Inclusion criteria: * patients with suspected Cushing's syndrome with clinical findings suggestive of Cushing's syndrome and positive screening tests (urinary free cortisol and low dose overnight dexamethasone suppression test). Exclusion criteria: none

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

General Clinical Research Center, University of Michigan Health System

Ann Arbor, United StatesSee the location
CompletedOne Study Center